Sonnex Energie vs AKCOME - solar panel manufacturer comparison

Sonnex Energie GmbH is a German manufacturer headquartered in Frankfurt am Main, incorporated in early 2021, making it a notably young entrant in the solar space with no confirmed public stock listing. AKCOME, by contrast, was founded in 2003 and operates out of Jiangsu Province, China, with a reported HJT production capacity of roughly 6 GW and an additional 4.6 GW expansion underway, giving it a meaningfully larger industrial footprint. Neither manufacturer currently holds BloombergNEF Tier 1 bankability status - AKCOME appeared on the list in Q4 2023 but was subsequently removed, while Sonnex has not appeared on the list at all - a consideration that matters for project finance and long-term warranty backstop credibility.

The two lineups serve quite different market segments. Sonnex builds its entire portfolio around N-type TOPCon cells, with an average output of 427.5 Wp and a peak of 440 Wp, average module efficiency of 21.9% and a high of 22.5%, and half its panels are bifacial. Its temperature coefficient of -0.315%/°C is standard for TOPCon. That profile suits premium residential rooftops and small commercial installations where physical module size and aesthetics matter. AKCOME goes all-in on HJT technology across its entire catalog, with an average output of 671.7 Wp and a ceiling of 700 Wp, average efficiency of 21.6% and a top of 22.54%, every panel bifacial, and a notably low temperature coefficient of just -0.24%/°C. That combination is squarely aimed at utility-scale ground mounts and large commercial arrays in warm climates where heat-driven losses compound quickly. Both manufacturers offer 30-year warranties.

For a typical utility or large C and I buyer in 2025, AKCOME's higher wattage, fully bifacial lineup, and superior temperature coefficient give it a clear edge in energy yield per installation. For residential buyers or those sourcing from a European supply chain, Sonnex is the more natural fit, though its very short track record remains a genuine risk factor worth weighing against both options' non-Tier-1 standing.

Generated by Claude Sonnet · 2026-05-11